Breaking AI & Tech News Analyzed

The UK government's proposal to boost North Sea oil and gas drilling is unlikely to provide relief to consumers in the form of lower energy prices. Oil prices have surged to $100 a barrel following the US and Israel's attack on Iran, with potential increases to $150 a barrel due to supply issues in the Strait of Hormuz.Kemi Badenoch, leader of the Conservative party, has introduced a plan to 'get Britain drilling' by opening new oil and gas fields in the North Sea. However, experts argue that this will not reduce energy bills for UK consumers. Oil and gas are sold on international markets, and prices are set globally, so there is no direct discount for UK consumers.The Conservative party has previously acknowledged this, but now suggests that tax reforms and removal of VAT on bills could deliver £200 cuts to household energy bills. The plan involves scrapping the windfall tax on North Sea producers, which has raised about £12bn so far.Critics argue that the windfall tax is essential and that removing it would not stimulate production significantly. The tax does not increase prices to consumers and has the support of the International Energy Agency.Analysis suggests that redirecting tax revenues from the North Sea back to consumers would have a minimal impact on bills. A study found that households would gain only about £16 a year if tax revenues from a maximally exploited North Sea were redistributed.Badenoch's claims about job creation in the North Sea are also disputed. The sector is declining, and geology, not politics, will dictate the future of North Sea oil and gas. Most of the UK's sector has already been drained, with only about 218m tonnes of oil recoverable by 2050 from existing fields.New drilling could add only 74m tonnes of oil and 1.1% to gas production, equivalent to putting off the end of the North Sea by a year or two. Job losses in the sector are a concern, with at least 70,000 jobs lost in the decade to 2024.Experts stress that renewable energy sources are a more secure and sustainable alternative. The UK should focus on creating conditions for clean energy infrastructure to attract investment and drive growth.

The families of British citizens held in the United Arab Emirates over allegations that they shared images of the conflict with Iran have expressed frustration at the British government's failure to help.Several British citizens are among more than 100 foreign nationals who have been detained under draconian Emirate rules that outlaw publishing or sharing material that could 'disturb public security'.UK government ministers have refused to condemn the arrests, amid claims they are too fearful of offending the Emirates because of their economic clout.The campaign group Dubai Watch, which is supporting nine British detainees, said their identities could not be revealed for fear of reprisals. But it has shown the Guardian anonymised correspondence from their increasingly anxious families.A mother whose daughter is being held wrote: 'This experience is exhausting, mentally and emotionally.'She described reading media reports about the continuing conflict in which Iran has retaliated against US and Israelis strikes by firing drones and missiles against its Gulf neighbours, including the UAE.She said: 'I have just read another article, and quite frankly I could do one purely on the inadequacies and sycophantic responses from this [UK] embassy.'She also expressed increasing fears for her daughter's safety as attacks continued. The mother said: 'I spoke to [my daughter] last night and they are no longer allowed to go outside in the courtyard as it's now deemed too dangerous to do so. This is an even bigger worry as they are all just sitting ducks.'Another message from a woman whose husband had been detained under the same law said the case had been 'mishandled'. She added: 'We are scared because nobody is telling us the truth. Can you please help us.'Police in Abu Dhabi said those detained had 'filmed sites and events and disseminated inaccurate information via social media platforms during the ongoing events, an action that could stir public opinion and spread rumours among community members'. In a statement, the officials said these 'violations' amounted to a 'misuse of social media'.Daisy Cooper, the deputy leader of the Liberal Democrats, confirmed that one of the detainees was a St Albans' constituent. She said their family was frustrated by the lack of consular help.Cooper told the Guardian: 'I'm deeply concerned that my constituent has been held with very little contact with their family, with no clear access to legal counsel, and no confirmation that UK consular officials have been permitted to visit them. The family are distressed and desperate for information about their wellbeing.'Cooper also criticised the UAE's round-up of anyone it has accused of sharing images of the conflict. She said: 'The response from the authorities appears wholly disproportionate given the nature of the allegations.'The Foreign, Commonwealth and Development Office confirmed that five UK nationals were receiving consular assistance in the UAE.David Haigh, a human rights lawyer and founder of Dubai Watch, said: 'There's an awful lot more than five cases. The embassy is overwhelmed.'He added: 'There hasn't been any government intervention because it would offend the UAE and they don't want to do that. Impotent is the best way to describe the response. They're too scared – it's all about the money and investment from the UAE.'

The U.S. Food and Drug Administration announced on Wednesday that it has granted expedited approval to Eli Lilly’s oral weight‑loss medication, orforglipron—marketed under the brand name Foundayo. This makes Foundayo the second GLP‑1 pill to reach U.S. consumers, following Novo Nordisk’s Wegovy tablet approved in December. Orforglipron works by mimicking a natural hormone that regulates appetite and satiety, offering a non‑injectable alternative to existing GLP‑1 injectables. David A. Ricks, Eli Lilly’s chair and CEO, highlighted that fewer than one in ten eligible patients are currently using GLP‑1 therapies, citing barriers such as cost, stigma, and perceived complexity. Unlike Wegovy, which must be taken on an empty stomach each morning, Foundayo can be taken anytime of day regardless of meals, simplifying dosing schedules. Patients will start on a low dose that is gradually increased to mitigate side‑effects. Pricing is projected at $149 per month for the initial dose, with higher‑strength formulations potentially reaching $349 monthly. While private‑insurance coverage remains uncertain, a Trump‑administration proposal could allow Medicare to cover certain patients as early as this summer, with copayments as low as $50 per month. Distribution will commence on Monday through LillyDirect’s direct‑to‑consumer channel, with broader availability in pharmacies and telehealth platforms expected shortly thereafter. The convenience of a once‑daily pill is anticipated to improve adherence, especially for individuals who avoid injectables due to needle aversion or rigid dosing requirements. The approval follows a fast‑track submission submitted only months ago, positioning Foundayo to enter the market roughly three months after Wegovy. This rapid rollout is set to intensify competition in the burgeoning GLP‑1 space, where new agents are continually emerging with claims of better efficacy and lower costs.

The moon is becoming a focal point for a new era of space exploration and exploitation, with multiple companies and countries racing to harness its resources. Interlune, a Seattle-based company, has raised $18m to fund its efforts to mine the moon for Helium-3, a rare gas that could become vital in quantum computers and nuclear fusion.Helium-3, deposited on the moon's surface over billions of years by the solar wind, is used in medical imaging but is in extremely short supply on Earth. Rob Meyerson, founder of Interlune, believes that extracting this resource could be economically viable due to its high value.Private access to space has become more feasible through companies like Blue Origin and SpaceX, making lunar mining a possibility. Interlune plans to send a multispectral camera to the lunar south pole to assess Helium-3 concentrations and is working towards a future mission called 'Prospect Moon' to gather samples.The lunar mining initiative raises questions about environmental impact and the ethics of extracting resources from the moon. Critics argue that history has shown pioneers rushing into unknown frontiers and causing irreparable damage. There are concerns about preserving the moon's pristine environment and protecting sites of extraordinary scientific importance.Legal aspects of moon mining are also unclear, with the 1967 Outer Space Treaty prohibiting national claims of ownership but making no reference to commercial activities. Despite these challenges, Interlune and other companies are pushing forward, with China also actively exploring the moon's resources, including Helium-3.

Israel has unleashed a significant military operation against Iran, launching two waves of attacks on Tehran and killing a senior Hezbollah commander. The attacks have escalated tensions in the region, with Iran's president, Masoud Pezeshkian, denying claims of a ceasefire request.US President Donald Trump has claimed that Iran's leadership is seeking a ceasefire, but Iran's foreign ministry spokesperson has denied this, calling Trump's account 'false and baseless'.The conflict has resulted in at least 1,900 people killed and 20,000 injured in Iran, according to estimates from the International Federation of Red Cross and Red Crescent societies. The Israeli military has also reported that 10 of its soldiers have been killed since fighting broke out on the Lebanese front.The attacks have had significant economic implications, with the strait of Hormuz effectively closed to oil and gas tankers and other merchant shipping since the beginning of the conflict, hiking oil prices and causing critical shortages around the world.Iran's president has written to Americans, asking which of their interests are being served by this war, and stating that Iranians 'harbor no enmity towards other nations, including the people of America'. The conflict continues to escalate, with further waves of attacks reported across the densely populated centre of Israel.

TV veteran Michael Patrick King has had a storied career, writing, directing, and producing shows like Murphy Brown, Will & Grace, and 2 Broke Girls. He's best known for his work on the Sex and the City franchise, serving as showrunner and writing and directing its two films.King's latest project is the return of his critically acclaimed show The Comeback, which first aired in 2005. The series, co-created and co-written with Lisa Kudrow, follows the story of Valerie Cherish, a sitcom star trying to return to stardom through reality TV. After a successful second season in 2014, fans have been clamoring for a third installment.The new season of The Comeback begins in the midst of a Hollywood strike, with Valerie navigating an industry in distress. The show tackles timely topics, including the rise of AI in television. King and Kudrow conducted extensive research on AI, consulting with experts to create a realistic portrayal.King also reflects on And Just Like That, the Sex and the City revival, which ended its three-season run last year. Despite initial backlash, King believes the series will age well and that its portrayal of older women challenging societal norms is a significant step forward.Throughout his career, King has demonstrated a willingness to take risks and push boundaries. As he says, 'We got cancelled and we're still here – 21 years later.'

Palantir’s claim that opposition to its NHS contract is driven by ideology was rebuked by Chi Onwurah, the Labour MP who chairs Parliament’s science, innovation and technology select committee. Onwurah said it is appropriate for ministers to explore a break‑clause option in the deal, underscoring the seriousness of the concerns raised. Louis Mosley, Palantir’s UK executive vice‑chair, had urged the government not to succumb to “ideologically motivated campaigners” as officials weighed a way out of a £330 million contract to deliver the Federated Data Platform (FDP) for NHS England. Ministers have now asked for advice on triggering the contract’s break clause amid growing scrutiny of Palantir’s expanding role in the public sector. The FDP is an AI‑enabled platform designed to integrate disparate health information across the NHS. Palantir already holds contracts with the Ministry of Defence, several police forces and the UK’s financial watchdog, the FCA. Onwurah’s cross‑party committee is set to publish its report in the coming weeks, covering the digital reorganisation of government services and the role of AI after a series of hearings that included experts, NHS leaders and representatives from companies such as Palantir. She identified three core issues: the manner in which the contract was awarded, the handling of patient data and the resulting trust deficit within the NHS, and the involvement of Peter Mandelson through his firm Global Counsel. “These are not fringe ideological concerns,” Onwurah told the Guardian. “They relate to contract transparency, vendor lock‑in, value for money and data security – matters that should concern everyone pushing the NHS towards digital transformation.” She added that the NHS’s post‑COVID fatigue and austerity‑driven burnout make any additional trust‑related resentment a significant barrier to progress. Onwurah noted that Palantir secured the contract after providing services to the NHS at a nominal cost – a tactic often used by large tech firms to position themselves as the most attractive government supplier. “It is right for the government to explore all options, including breaking the contract, given ongoing concerns about FDP uptake while Palantir remains at the helm,” she said. Liberal Democrat MP Martin Wrigley, also on the committee, urged the government to commission a new consortium of UK‑based tech experts to build a home‑grown NHS platform. During a previous committee appearance, Mosley accused British doctors of placing “ideology over patient interest” after they challenged the data‑processing contract. Speaking to the Times, Mosley warned that removing Palantir could jeopardise patient care and stall solutions to the NHS’s biggest challenges, arguing that the campaign against the firm would do more harm than good.

In a recent interview published by the Free Press, former UK prime minister Tony Blair asserted that the British left has entered an “unholy alliance” with Islamist groups, framing criticism of Israel’s Gaza operations as a new form of anti‑semitism. He further praised former President Donald Trump’s proposed plan for Gaza, describing it as “bold and intelligent.”The commentary arrives amid a sharp decline in British public support for Israel. A YouGov poll found that only 12 % of respondents back Israel’s actions in Gaza, while a clear majority favor measures such as an arms embargo, sanctions, and even the prosecution of Prime Minister Benjamin Netanyahu for alleged war crimes.Blair’s allegation that the left “casts the Jewish community as supporters of the Israeli government” is challenged by evidence of a broader shift in public sentiment. The Greens, now a leading force on the English left, oppose the Gaza offensive and reject Islamophobia, yet they are led by a Jewish gay politician and champion a socially progressive agenda that includes LGBTQ+ rights and gender equality—hardly the hallmarks of “Islamism.”Data on American Jewry is also invoked. While 71 % of Jewish Americans voted for Kamala Harris in the 2024 election, a separate poll indicated that 40 % of Jewish respondents believe Israel’s military actions amount to genocide, a figure rising to half among those under 35. These figures illustrate that criticism of Israel does not automatically equate to anti‑semitic sentiment.The piece also revisits Blair’s own controversial foreign‑policy record. His government approved extensive arms sales to Saudi Arabia and shut down investigations into those deals, while his post‑premiership institute continued to receive substantial Saudi funding even after the murder of journalist Jamal Khashoggi. Moreover, the 2003 invasion of Iraq, led by Blair, is widely regarded as having provided a recruitment boost to Islamist extremist groups.Critics argue that Blair’s narrative is a strategic attempt to deflect growing Western criticism of Israel by painting opponents as extremist sympathizers. The term “Islamo‑gauchisme,” used in France to describe similar accusations, exemplifies a broader pattern of demonising Muslim participation in democratic politics.In sum, the article contends that Blair’s claim lacks substantive evidence, overlooks prevailing public opinion, and mirrors past tactics of smearing dissenting voices. As the debate over Israel’s conduct in Gaza intensifies, the left’s opposition appears rooted in humanitarian concerns rather than any covert Islamist agenda.

The England and Wales Cricket Board (ECB) is facing criticism from parents of learning‑disability cricketers who say the board has permitted non‑disabled players to compete in the Disability Premier League (DPL), jeopardising the league’s role as the top feeder for England’s mixed‑disability side.Parents of former England internationals Jai Charan and Alex Jervis claim their sons were replaced by players who do not meet the ECB’s learning‑disability (LD) criteria. An anonymous parent estimates that 12 of the 64 players drafted in December were not disabled, a figure that, if accurate, would represent a significant breach of the league’s purpose.The DPL is intended to be the pinnacle of the pathway to the England Mixed‑Disability team. Under the ECB’s affiliation with Virtus – the global federation for athletes with intellectual impairments – any cricketer seeking an LD spot must demonstrate an IQ of 75 or below, as assessed by an educational psychologist.Owen Jervis, volunteer manager of Yorkshire’s disability team, alleges that several neurodiverse athletes have been fielded despite failing the LD assessment. He notes that most neurodiverse players would not satisfy the eligibility thresholds, citing professional bowler Em Arlott, diagnosed with ADHD and autism in 2023, as an example of a mainstream player with a neurodiverse profile.While the ECB is not legally bound to apply Virtus rules to a domestic competition, critics argue that the inclusion of non‑disabled players undermines the league’s integrity. “You can’t call it a Disability Premier League if the players aren’t disabled,” said Tracey Jervis.Another parent highlighted that his son, a learning‑disability cricketer, is now confined to county disability cricket rather than mainstream county cricket, where many England‑qualified players develop. He warned that the DPL has become an “old‑boys’ club” where selection is driven by personal connections rather than merit.The shift to a mixed‑disability format – combining learning, physical and deaf impairments in the same squads – has further reduced available spots. Parents claim that players without a qualifying LD are occupying key batting and bowling positions, relegating genuine LD athletes to peripheral roles such as fielding or carrying equipment.Owen Jervis raised these concerns with Richard Hill, the ECB’s events and competition manager for disability cricket, in September 2024. Hill acknowledged “several challenges” linked to high‑functioning conditions and said the ECB was drafting an action plan, though Jervis says the situation has worsened.Jai Charan, who debuted for the England LD team in 2023 and holds the DPL’s best bowling average and strike‑rate, and Alex Jervis, a decade‑long LD representative and three‑time LD Ashes winner, were reduced to non‑playing roles in the 2025 season. Charan’s father, Shanial Charan, expressed his disappointment: “My son has the best stats in the league yet he isn’t selected – it feels like discrimination within disability cricket.”The ECB responded that the DPL offers top‑level competition for 60 mixed‑disability players annually, with a strict quota for physical, learning and deaf impairments, making selection highly competitive. It acknowledged ongoing debates about eligibility and indicated a review slated for 2027 to potentially adjust criteria.